Live data · NADAC + Part D CY24 · reviewed daily

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine

First FDA approval2002-06-14
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$0.233/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.465
Across all dosage forms in distribution.
Highest NADAC
$0.597
Range is tight.
Plans with PA
65 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema5 entries indexed · 4 visible
What is Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine used for?

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Is there a generic for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine?

No. Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine is brand-only with no generic equivalents currently in market.

How much does my plan pay for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine?

Across 329 Part D plans, Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine averages $0.465/unit (NADAC). Lowest available: $0.233/unit. Highest in distribution: $0.597/unit.

Is Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine on the FDA shortage list?

No. Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine and Amphetamine is not currently on the FDA Drug Shortage Database.

1 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.